SARS- COV-2 among Pediatrics
| dc.contributor.author | Yousif M Elhaj | |
| dc.contributor.author | Mosab Nouraldein Mohammed Hamad | |
| dc.date.accessioned | 2023-11-27T09:53:24Z | |
| dc.date.available | 2023-11-27T09:53:24Z | |
| dc.date.issued | 2020-07-11 | |
| dc.description.abstract | Abstract SARS COV-2 has been stated a pandemic by the World Health Organization as established cases come up to more than 11.200.000 patients with what will exceed 528.000 deaths across over the world. COVID-19 can look dissimilar in different people. For numerous people, being unwell with COVID-19 would be a little bit like having the flu. People can get a fever, cough, or have a hard time taking deep breaths. The majority people who have gotten COVID-19 have not gotten very sick. Merely a small group of people who get it have had more grave problems. Most kids do not show to be at higher risk for COVID-19 than adults. As some children and infants have been sick with COVID-19, adults make up most of the known cases to date. Alterations of clinical manifestation between children and adults infected with SARS COV-2 were attributed to differences in immune response, which is depending on the levels of immuno-modulating agents. Several diagnostic methods were implemented to support the clinical diagnosis, up to date there is no constant protocol to treat SARS COV-2 whether in children or adults, extensive researches are needed to face this pandemic crisis. . | |
| dc.identifier.uri | https://ds.eaeu.edu.sd/handle/10.58971/542 | |
| dc.language.iso | other | |
| dc.publisher | جامعة الشيخ عبدالله البدري | |
| dc.title | SARS- COV-2 among Pediatrics |